
Sign up to save your podcasts
Or


Questions continue to grow about air safety in the US capital. We hear from Graham Braithwaite, professor of safety and accident investigation, at Cranfield University.
Crispr designed gene cutting therapy for some patients with severe sickle cell disease, approved for NHS use.
The ‘godfather of artificial intelligence’ issues stark warning that the technology could one day replace humans.
Also in this episode:
Hosted on Acast. See acast.com/privacy for more information.
By The Evening Standard3.8
55 ratings
Questions continue to grow about air safety in the US capital. We hear from Graham Braithwaite, professor of safety and accident investigation, at Cranfield University.
Crispr designed gene cutting therapy for some patients with severe sickle cell disease, approved for NHS use.
The ‘godfather of artificial intelligence’ issues stark warning that the technology could one day replace humans.
Also in this episode:
Hosted on Acast. See acast.com/privacy for more information.

892 Listeners

55 Listeners

65 Listeners

607 Listeners

11 Listeners

413 Listeners

239 Listeners

157 Listeners

1 Listeners

21 Listeners

94 Listeners

120 Listeners

15,887 Listeners

19 Listeners

0 Listeners

3,374 Listeners

645 Listeners

966 Listeners

0 Listeners

8 Listeners

2 Listeners

3 Listeners